Skip to content
Gold Mining News – Lifestyle
Author:
Apotex Health Corp.
Apotex launches Axitinib Tablets in the U.S., the first generic version of INLYTA®
November 16, 2026
Apotex Delivers Strong Second Quarter 2027 Results and Raises FY2027 Guidance
November 12, 2026
Apotex Announces First Quarter 2027 Results
August 12, 2026
Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement
July 16, 2026